Those children who survive this massive insult, however, seem to make a complete clinical recovery. All survivors were leading a normal life within four weeks of discharge from hospital. Nevertheless, liver biopsy specimens from most survivors in the King's study showed appreciable inflammatory change, sufficient to warrant a histological diagnosis of chronic aggressive hepatitis. Subsequent repeat specimens showed postnecrotic scarring. Adult survivors normally show rapid and complete histological recovery. '2 Clearly children with such a severe and complex disease should be managed in specialised units. Only in this way will survival be improved in this potentially treatable disease. Transfer of very sick patients over large distances may be a problem; they should be accompanied by a doctor and a nurse, and on the journey intravenous fluids should be carefully controlled, giving high concentrations of glucose to prevent hypoglycaemia and limiting excessive sodium and water intake. Psacharopoulos prognosis.
The degree of disability was assessed on the McAlpine scale2 as: no disability (grades 0-1), moderate disability (still ambulatory, grades 2-3), and severe disability (non-ambulatory, grades 4-6). There was a strong correlation of the age of onset with the interval to moderate disability: this interval averaged eight years in the youngest patients with age of onset at 20 but only one year in patients aged 50 at onset. Severe disability developed after 14-3 years in the young and after 4-8 years in the older patients. Ten per cent died within 15 years, and this suggests a mean survival time of around 30 years.
The disability score and duration of the disease were combined to define various forms of the disease. Patients with benign forms6 8 (constituting 14% of all patients) show no disability after 10 years and moderate disability after 15 years. Whereas McAlpine6 found a low relapse rate in the second year, Confavreux et a15 commented that the number of relapses in the remittent phase had an interesting relation to outcome, the "benign" forms having a greater number of relapses. In contrast, patients with the "hyperacute" form (8% of the total) were severely disabled within less than five years. Hyperacute forms were three times more common in patients with a progressive than those with a remittent onset. Overall, a late onset of the disease, a short interval between the first two relapses, and the occurrence of the progressive phase were all associated with a poor outcome. 
